4.2 Article

APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome

Journal

RETROVIROLOGY
Volume 9, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1742-4690-9-113

Keywords

Hypermutated HIV; APOBEC3G; APOBEC3F; Motif representation; G-to-A mutation signature

Categories

Funding

  1. Australian National Health and Medical Research Council (NHMRC)
  2. Australian Government
  3. University of New South Wales
  4. NHMRC

Ask authors/readers for more resources

Background: The human immune proteins APOBEC3G and APOBEC3F (hA3G and hA3F) induce destructive G-to-A changes in the HIV genome, referred to as 'hypermutation'. These two proteins co-express in human cells, co-localize to mRNA processing bodies and might co-package into HIV virions. Therefore they are expected to also co-mutate the HIV genome. Here we investigate the mutational footprints of hA3G and hA3F in a large population of full genome HIV-1 sequences from naturally infected patients to uniquely identify sequences hypermutated by either or both of these proteins. We develop a method of identification based on the representation of hA3G and hA3F target and product motifs that does not require an alignment to a parental/consensus sequence. Results: Out of nearly 100 hypermutated HIV-1 sequences only one sequence from the HIV-1 outlier group showed clear signatures of co-mutation by both proteins. The remaining sequences were affected by either hA3G or hA3F. Conclusion: Using a novel method of identification of HIV sequences hypermutated by the hA3G and hA3F enzymes, we report a very low rate of co-mutation of full-length HIV sequences, and discuss the potential mechanisms underlying this.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Epigenetics of Triple-Negative Breast Cancer via Natural Compounds

Mohammed Kaleem, Maryam Perwaiz, Suza Mohammad Nur, Abdulrasheed O. Abdulrahman, Wasim Ahmad, Fahad A. Al-Abbasi, Vikas Kumar, Mohammad Amjad Kamal, Firoz Anwar

Summary: TNBC is a highly resistant, lethal, and metastatic subtype of breast cancer characterized by the deficiency of ER, PR, and HER2. It shows higher aggressiveness and poorer prognosis in women, with a higher recurrence rate during reproductive age. TNBC is defined by the presence of EMT and exhibits specific epigenetic markers.

CURRENT MEDICINAL CHEMISTRY (2022)

Article Immunology

Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial.

Deborah Cromer, Arnold Reynaldi, Megan Steain, James A. Triccas, Miles P. Davenport, David S. Khoury

Summary: The vaccine candidate CVnCoV (CUREVAC) exhibited lower efficacy compared to other mRNA vaccines in a recent phase 3 trial, which can be attributed to the dosage used and the presence of SARS-CoV-2 variants. The neutralizing antibody response induced by the vaccine can predict the low efficacy.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design

Jillian S. Y. Lau, Deborah Cromer, Mykola Pinkevych, Sharon R. Lewin, Thomas A. Rasmussen, James H. McMahon, Miles P. Davenport

Summary: This study used mathematical models to explore ways to improve ATI study design to maximize statistical power and minimize risks to participants.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice

Arya SheelaNair, Aleksandra S. Romanczuk, Rosemary A. Aogo, Rohit Nemai Haldar, Lianne I. M. Lansink, Deborah Cromer, Yandira G. Salinas, R. Kiplin Guy, James S. McCarthy, Miles P. Davenport, Ashraful Haque, David S. Khoury

Summary: This study compared the effects of different anti-malarial drugs on mice infected with malaria. The results showed that different drugs varied in their ability to reduce parasite count and had different mechanisms of action. This suggests that although the parasite clearance curves may be similar, the drugs have different capacities to inhibit, kill, and clear parasites.

MALARIA JOURNAL (2022)

Article Multidisciplinary Sciences

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel G. Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett Gosnell, Salim S. Abdool Karim, Willem Hanekom, Anne von Gottberg, Jinal N. Bhiman, Richard J. Lessells, Mahomed-Yunus S. Moosa, Miles P. Davenport, Tulio de Oliveira, Penny L. Moore, Alex Sigal

Summary: The study found that the Omicron variant has reduced neutralizing effectiveness in individuals vaccinated with Pfizer BNT162b2, but those who had previously been infected with SARS-CoV-2 showed better neutralization against Omicron.

NATURE (2022)

Review Biochemistry & Molecular Biology

Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment

Muhammad Shahid Nadeem, Imran Kazmi, Inam Ullah, Khushi Muhammad, Firoz Anwar

Summary: Allicin is a defense molecule produced by garlic cells, which has antioxidant and neuroprotective properties. It has potential therapeutic effects on various diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders.

ANTIOXIDANTS (2022)

Article Pharmacology & Pharmacy

Alterations in Clinical Characteristics of Blood Donors Post COVID-19 Recovery

Fahad Al Ghamdi, Salma Naqvi, Fahad A. Alabassi, Sultan Alhayyani, Mirza Rafi Baig, Vikas Kumar, Firoz Anwar

Summary: This study analyzed various factors, including blood type, blood pressure, age, and physical characteristics, related to the prognosis of COVID-19 infection. The results found that individuals with blood type O+ were more susceptible, and blood pressure and pulse rate increased with age. Males exhibited greater variation in systolic blood pressure, with the Rh+ factor playing a predominant role. Individuals above 45 years of age and with a high BMI had significantly elevated blood pressure and pulse rate.

CURRENT PHARMACEUTICAL DESIGN (2022)

Article Biochemistry & Molecular Biology

Pharmacological role of Vitamin C in stress-induced cardiac dysfunction via alteration in Gut microbiota

Firoz Anwar, Sultan Alhayyani, Fahad A. Al-Abbasi, Muhammad Shahid Nadeem, Vikas Kumar

Summary: Emerging evidence suggests a strong association between gut microbiota and cardiovascular metabolic functions. Cardiac diseases may alter the richness, diversity, and composition of the gut microbiome. Vitamin C plays an important role in cardiovascular diseases. In a study using a forced swim stress model in rats, cardiac remodeling was induced, resulting in dysbiosis. Treatment with high doses of Vitamin C showed positive outcomes on cardiac complications by modulating the gut microbiota.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2022)

Article Immunology

Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory

Kathleen M. Wragg, Wen Shi Lee, Marios Koutsakos, Hyon-Xhi Tan, Thakshila Amarasena, Arnold Reynaldi, Grace Gare, Penny Konstandopoulos, Kirsty R. Field, Robyn Esterbauer, Helen E. Kent, Miles P. Davenport, Adam K. Wheatley, Stephen J. Kent, Jennifer A. Juno

Summary: Wragg and colleagues tracked clonal populations of spike-specific CD4(+) cT(FH) cells using MHC class II tetramers and TCR beta sequencing in convalescent individuals with COVID-19 or SARS-CoV-2-vaccinated individuals. They found that both infection and vaccination induced CD4(+) T cell responses to the spike protein and that these responses correlated with neutralizing antibodies. Secondary exposure led to the recall of CD4(+) T cells with a transitory CXCR3(+) phenotype and expansion of cT(FH) cells temporarily expressing ICOS, CD38, and PD-1. The study demonstrates that stable pools of cT(FH) and memory CD4(+) T cells established by infection and/or vaccination can be efficiently recalled and may contribute to long-term protection against SARS-CoV-2.

NATURE IMMUNOLOGY (2022)

Editorial Material Cell Biology

Nice and slow make the germinal centers go: measured and escalating antigen delivery enhance durability and quality of humoral immune responses against HIV-1

Hyon-Xhi Tan, Miles P. Davenport, Stephen J. Kent, Adam K. Wheatley

IMMUNOLOGY AND CELL BIOLOGY (2022)

Article Multidisciplinary Sciences

Early microbial exposure shapes adult immunity by altering CD8+T cell development

Cybelle Tabilas, David S. Iu, Ciaran W. P. Daly, Kristel J. Yee Mon, Arnold Reynaldi, Samantha P. Wesnak, Jennifer K. Grenier, Miles P. Davenport, Norah L. Smith, Andrew Grimson, Brian D. Rudd

Summary: Microbial exposure during development can have long-lasting effects on an individual's health, but how early microbial exposure leads to permanent changes in the immune system is still unclear. This study shows that early microbial exposure results in the preferential expansion of specific CD8+ T cell populations, which persist and provide enhanced immune protection against intracellular pathogens. Interestingly, this microbial education occurs during thymic development and involves changes in epigenetic programming.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Multidisciplinary Sciences

Natural sea salt in diet ameliorates better protection compared to table salt in the doxorubicin-induced cardiac remodeling

Firoz Anwar, Turky Omar Asar, Fahad A. Al-Abassi, Vikas Kumar, Sultan Alhayyani

Summary: This study investigates the effect of a diet mixed with sea and table salts on cardiac remodeling and finds that the addition of natural sea salt has a significant beneficial effect on cardiac dysfunction.

JOURNAL OF TAIBAH UNIVERSITY FOR SCIENCE (2022)

Article Biochemistry & Molecular Biology

Predicting the efficacy of variant-modified COVID-19 vaccine boosters

David S. Khoury, Steffen S. Docken, Kanta Subbarao, Stephen J. Kent, Miles P. Davenport, Deborah Cromer

Summary: Booster vaccination is necessary to combat waning immunity and variants of SARS-CoV-2. Data on neutralization titers from multiple sources suggest that using ancestral vaccines can enhance protection against symptomatic and severe disease caused by variant viruses. Variant-modified vaccines may provide additional benefits. This study provides evidence-based guidance for future COVID-19 vaccine regimens.

NATURE MEDICINE (2023)

Article Multidisciplinary Sciences

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis

Deborah Cromer, Megan Steain, Arnold Reynaldi, Timothy E. Schlub, Shanchita R. Khan, Sarah C. Sasson, Stephen J. Kent, David S. Khoury, Miles P. Davenport

Summary: The study demonstrates a strong correlation between neutralising antibody titres and vaccine effectiveness against symptomatic and severe COVID-19. Predicted neutralising antibody titres are strongly correlated with observed vaccine effectiveness, and the loss of neutralising antibodies over time and to new variants is predictive of observed vaccine protection against severe COVID-19.

NATURE COMMUNICATIONS (2023)

Article Immunology

Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?

Stephen J. Kent, David S. Khoury, Arnold Reynold, Jennifer A. Juno, Adam K. Wheatley, Eva Stadler, E. John Wherry, James Triccas, Sarah C. Sasson, Deborah Cromer, Miles P. Davenport

Summary: Understanding the role of T cells in SARS-CoV-2 infection is crucial for the design of next-generation vaccines. This perspective discusses the challenges in determining the causal relationship between vaccine-induced T cell immunity and protection from COVID-19, and proposes an approach to gather evidence and clarify the role of vaccine-induced T cell memory in protecting against severe COVID-19.

NATURE REVIEWS IMMUNOLOGY (2022)

No Data Available